scholarly journals Nano-thermal imaging of the stratum corneum and its potential use for understanding of the mechanism of skin penetration enhancer

2017 ◽  
Vol 655 ◽  
pp. 278-283 ◽  
Author(s):  
Choon Fu Goh ◽  
Jonathan G. Moffat ◽  
Duncan Q.M. Craig ◽  
Jonathan Hadgraft ◽  
Majella E. Lane
RSC Advances ◽  
2018 ◽  
Vol 8 (48) ◽  
pp. 27464-27469 ◽  
Author(s):  
Mónika Bakonyi ◽  
Attila Gácsi ◽  
Szilvia Berkó ◽  
Anita Kovács ◽  
Erzsébet Csányi

The aim of this work was to investigate the applicability of stratum corneum lipid liposomes as in vitro skin models for studying skin penetration enhancer effect of Kolliphor RH40 and Transcutol.


2012 ◽  
Vol 48 (4) ◽  
pp. 811-817 ◽  
Author(s):  
Luís Antônio Dantas Silva ◽  
Stephânia Fleury Taveira ◽  
Eliana Martins Lima ◽  
Ricardo Neves Marreto

Clobetasol propionate (CP) is a potent topical corticosteroid that causes several cutaneous and systemic side effects. In the present work, CP was encapsulated in nanostructured lipid carriers (NLCs) to increase drug retention in the outer skin layers and improve the safety of topical therapy. NLCs were prepared using a microemulsion technique with a mixture of lecithin, taurodeoxycholate, stearic acid, and oleic acid. In vitro penetration studies were performed in a modified Franz-type diffusion cell, and porcine ears were used as a model of human skin. A simple and sensitive liquid chromatographic method was developed and validated for clobetasol determination in different skin layers. NLCs presented uniform size distribution, high zeta potentialand entrapment efficiency values (> 98%). The analytical procedure was validated according to FDA guidelines. Clobetasol recoveries from skin samples were higher than 85%, with no interference of skin components and NLC ingredients. In experiments, after 6 h, a higher drug accumulation in the stratum corneum arising from NLCs compared to aqueous CP solution was observed. Thus, the NLCs demonstrated high potential for targeting CP to the skin and ensuring drug accumulation in the stratum corneum.


2004 ◽  
Vol 285 (1-2) ◽  
pp. 43-49 ◽  
Author(s):  
Kyoung-Jin Lee ◽  
Sun-Joo Hwang ◽  
Jung Sun Kim ◽  
Dae-Duk Kim ◽  
Young-Hee Shin ◽  
...  

1992 ◽  
Vol 112 (9) ◽  
pp. 638-644 ◽  
Author(s):  
Tsuneo NAMBA ◽  
Kouji SEKIYA ◽  
Shigetoshi KADOTA ◽  
Masao HATTORI ◽  
Kazunori KATAYAMA ◽  
...  

2014 ◽  
Vol 63 (2) ◽  
pp. 141-147 ◽  
Author(s):  
Tomohiro Imura ◽  
Tomotake Morita ◽  
Tokuma Fukuoka ◽  
Mizuyuki Ryu ◽  
Keisuke Igarashi ◽  
...  

1995 ◽  
Vol 33 (2) ◽  
pp. 299-305 ◽  
Author(s):  
Johan Engblom ◽  
Sven Engström ◽  
Krister Fontell

Author(s):  
Francesco Cilurzo ◽  
Silvia Franzé ◽  
Umberto M Musazzi

The skin is the most important barrier of human body to prevent the absorption of exogenous substances. Its ability to limit the absorption of exogenous substances is exercised by the most superficial layer of the epidermis, the stratum corneum, which consists of about 15-20 layers of corneocytes supported by keratin fibres. The extracellular spaces are filled with a very dense lipid matrix organized in periodic lamellae, whereas the interlamellar spaces are constituted by a more fluid lipid matrix. In addition, where the corneocytes are not perfectly overlapped, pores with a higher water content are created. This complex organization allows only the passive diffusion of small molecules with peculiar chemical-physical properties. In all the other cases, it is necessary to improve the transdermal absorption of drugs using techniques able to alter reversibly the functionality of the stratum corneum, such as chemical skin penetration enhancers, iontophoresis or sonophoresis. In the era of nanotechnology, an intense effort has been made to design nanocarriers able to permeate the skin (e.g., polymeric nanoparticles, metal or solid-lipid, micro- and nanoemulsions, lipid vesicles). Nevertheless, the results are contradictory and there is scepticism in the scientific community about the real benefits of these systems compared to other traditional approaches. In fact, assuming the stratum corneum as a nanoporous membrane with openings of about 20-40 nm, the size of most of the nanocarriers is too big for permitting theoretically the skin penetration and diffusion. However, despite this consideration, on the market there are some medicinal products consisting of lipid vesicles. Starting from the critical analysis of the published information on possible permeation mechanisms of different types of nanocarriers, this review outlines lights and shadows on the (trans-)dermal administration of these drug delivery systems.


Sign in / Sign up

Export Citation Format

Share Document